Clinical Trial Update: An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR

View source ↗

Summary

This is a long-term follow-up clinical trial evaluating kidney transplant patients treated with imlifidase or plasma exchange after antibody-mediated rejection;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection

Drugs mentioned

• Imlifidase (imlifidase)

Snippet

Sponsor: Hansa Biopharma AB | Conditions: Kidney Transplant Rejection | Status: TERMINATED | Results posted: 2025-05-11